Cytori Therapeutics Inc Series S Warrant
CYTXZ
CYTXZ was delisted on the 23rd of July, 2019.
7 hedge funds and large institutions have $314K invested in Cytori Therapeutics Inc Series S Warrant in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
26% less capital invested
Capital invested by funds: $427K → $314K (-$113K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$411 |
Top Sellers
CYTXZ Hedge Fund Activity: Q4 2018 in Review
7 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Series S Warrant (CYTXZ) for Q4 2018, worth a combined $314K — down 26% from $427K a quarter earlier.
Fund positioning in CYTXZ was balanced in Q4 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $411.
- 7 institutional investors held Cytori Therapeutics Inc Series S Warrant (CYTXZ) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $314K of Cytori Therapeutics Inc Series S Warrant stock for Q4 2018, down 26% quarter-over-quarter.
- 1 fund opened new Cytori Therapeutics Inc Series S Warrant positions in Q4 2018 and 1 closed out, a net change of 0 holders.
- The largest Cytori Therapeutics Inc Series S Warrant buyer in Q4 2018 was Susquehanna International Group, an estimated $411 added.
Based on aggregated 13F filings for Q4 2018.